Search Results

Pancreatic cancer cases are on the rise and will become the second deadliest type of cancer in the United States by 2030. Doctors at UT Southwestern discuss the future of pancreatic cancer.

The rates of colorectal cancer in young adults have been on the rise, making screening more important than ever.

Underserved communities often have difficulty accessing cancer prevention resources. These cancer research studies aim to provide more equity for all patients.

Studies could lead to new treatments for cancer and autoimmune diseases.

An important piece of our program is the involvement of the Cancer Genetics team with the cancer support community and general patient education.

Researchers at UT Southwestern set out to understand the under-utilization of ACT in stage three colon cancer patients. Learn the impact on patient outcomes here.

Is colon cancer screening necessary? A study out of the U.K. published in The BMJ suggests average-risk patients age 50-79 might not need a colonoscopy if they have low risk-score. But Syed Kazmi, M.D., disagrees when it comes to U.S. patients. Find out why in this MedBlog.

Doctors and researchers are making strides every day in the fight against brain cancer. Read on to learn about some of the new developments underway at UT Southwestern.

A new immunotherapy drug combination has been dubbed a significant advancement in kidney cancer treatment. The combination of ipilimumab and nivolumab can improve outcomes and quality of life. Learn more.

Media coverage of celebrities with pancreatic cancer such as Alex Trebek and Ruth Bader Ginsburg can lead to misconceptions about typical outcomes.